842 related articles for article (PubMed ID: 22884155)
1. Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.
Niu LM; Liang Y; Xu M; Zhang YY; Zhang Y; He B
Chin Med J (Engl); 2012 Jun; 125(12):2213-8. PubMed ID: 22884155
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of the beta2 adrenoreceptor gene in chronic obstructive pulmonary disease.
Vacca G; Schwabe K; Dück R; Hlawa HP; Westphal A; Pabst S; Grohé C; Gillissen A
Ther Adv Respir Dis; 2009 Feb; 3(1):3-10. PubMed ID: 19293197
[TBL] [Abstract][Full Text] [Related]
3. Association of beta2-adrenoreceptor genotypes with bronchodilatory effect of tiotropium in COPD.
Umeda N; Yoshikawa T; Kanazawa H; Hirata K; Fujimoto S
Respirology; 2008 May; 13(3):346-52. PubMed ID: 18399855
[TBL] [Abstract][Full Text] [Related]
4. β2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies.
Thomsen M; Nordestgaard BG; Sethi AA; Tybjærg-Hansen A; Dahl M
Eur Respir J; 2012 Mar; 39(3):558-66. PubMed ID: 22075484
[TBL] [Abstract][Full Text] [Related]
5. hOGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms associated with chronic obstructive pulmonary disease.
Yang SF; Xu YJ; Xie JG; Zhang ZX
Chin Med J (Engl); 2009 Apr; 122(8):960-6. PubMed ID: 19493423
[TBL] [Abstract][Full Text] [Related]
6. Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbations of COPD.
Mokry M; Joppa P; Slaba E; Zidzik J; Habalova V; Kluchova Z; Micietova L; Rozborilova E; Salagovic J; Tkacova R
Med Sci Monit; 2008 Aug; 14(8):CR392-8. PubMed ID: 18667995
[TBL] [Abstract][Full Text] [Related]
7. Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1.
Brøgger J; Steen VM; Eiken HG; Gulsvik A; Bakke P
Eur Respir J; 2006 Apr; 27(4):682-8. PubMed ID: 16585076
[TBL] [Abstract][Full Text] [Related]
8. Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.
Rabe KF; Fabbri LM; Israel E; Kögler H; Riemann K; Schmidt H; Glaab T; Vogelmeier CF
Lancet Respir Med; 2014 Jan; 2(1):44-53. PubMed ID: 24461901
[TBL] [Abstract][Full Text] [Related]
9. The protease inhibitor PI*S allele and COPD: a meta-analysis.
Dahl M; Hersh CP; Ly NP; Berkey CS; Silverman EK; Nordestgaard BG
Eur Respir J; 2005 Jul; 26(1):67-76. PubMed ID: 15994391
[TBL] [Abstract][Full Text] [Related]
10. Influence of β(2)-adrenergic receptor polymorphisms on asthma exacerbation in children with severe asthma regularly receiving salmeterol.
Giubergia V; Gravina L; Castaños C; Chertkoff L
Ann Allergy Asthma Immunol; 2013 Mar; 110(3):156-60. PubMed ID: 23548523
[TBL] [Abstract][Full Text] [Related]
11. Association Between ADRB2 Genetic Polymorphisms and the Risk of Chronic Obstructive Pulmonary Disease: A Case-Control Study in a Chinese Population.
Zhao H; Wu X; Dong CL; Wang BY; Zhao J; Cao XE
Genet Test Mol Biomarkers; 2017 Aug; 21(8):491-496. PubMed ID: 28753063
[TBL] [Abstract][Full Text] [Related]
12. β
Ingebrigtsen TS; Vestbo J; Rode L; Marott JL; Lange P; Nordestgaard BG
Thorax; 2019 Oct; 74(10):934-940. PubMed ID: 31481635
[TBL] [Abstract][Full Text] [Related]
13. Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD.
Hizawa N; Makita H; Nasuhara Y; Betsuyaku T; Itoh Y; Nagai K; Hasegawa M; Nishimura M
Chest; 2007 Nov; 132(5):1485-92. PubMed ID: 17890463
[TBL] [Abstract][Full Text] [Related]
14. Combination of polymorphisms in the beta2-adrenergic receptor and nitric oxide synthase 3 genes increases the risk for hypertension.
Misono M; Maeda S; Iemitsu M; Nakata Y; Otsuki T; Sugawara J; Zempo H; Yoshizawa M; Miyaki A; Kuno S; Matsuda M; Ajisaka R
J Hypertens; 2009 Jul; 27(7):1377-83. PubMed ID: 19373110
[TBL] [Abstract][Full Text] [Related]
15. Association of gene polymorphisms of tumour necrosis factor-alpha and interleukin-13 with chronic obstructive pulmonary disease in Han nationality in Beijing.
Jiang L; He B; Zhao MW; Ning LD; Li XY; Yao WZ
Chin Med J (Engl); 2005 Apr; 118(7):541-7. PubMed ID: 15820084
[TBL] [Abstract][Full Text] [Related]
16. Association of asthma with beta(2)-adrenergic receptor gene polymorphism and cigarette smoking.
Wang Z; Chen C; Niu T; Wu D; Yang J; Wang B; Fang Z; Yandava CN; Drazen JM; Weiss ST; Xu X
Am J Respir Crit Care Med; 2001 May; 163(6):1404-9. PubMed ID: 11371409
[TBL] [Abstract][Full Text] [Related]
17. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
[TBL] [Abstract][Full Text] [Related]
18. Beta-2-adrenoreceptor polymorphism at position 16 determines the clinical severity of chronic obstructive pulmonary disease.
Emeryk-Maksymiuk J; Emeryk A; Krawczyk P; Wojas-Krawczyk K; Milanowski J
Pulm Pharmacol Ther; 2017 Apr; 43():1-5. PubMed ID: 28093224
[TBL] [Abstract][Full Text] [Related]
19. Association between polymorphism of glutathione S-transferase P1 and chronic obstructive pulmonary disease: a meta-analysis.
Yan F; Chen C; Jing J; Li W; Shen H; Wang X
Respir Med; 2010 Apr; 104(4):473-80. PubMed ID: 20117922
[TBL] [Abstract][Full Text] [Related]
20. [Study on beta 2 adrenergic receptor genetic polymorphisms in asthmatics in the people of the Han nationality of northern China].
Gao G; Wang S; Zhang J
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Feb; 23(2):93-7. PubMed ID: 11778498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]